Vimarsana
Biggest News Aggregation in the World

Mitchell Steiner News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mitchell Steiner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mitchell Steiner Today - Breaking & Trending Today

Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25% - Vimarsana News

Individual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%

Key Insights Veru's significant individual investors ownership suggests that the key decisions are influenced by...

Source: yahoo.com
Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss - Vimarsana News

Veru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight Loss

MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innova...

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript - Vimarsana News

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript

Veru Inc. (NASDAQ:VERU) Q1 2024 Earnings Call Transcript February 8, 2024 Veru Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to the Veru Inc. Investor Conference Call. [Operator Instructions] Please note, this […]

Source: yahoo.com
Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs - Vimarsana News

Veru Announces FDA Clearance of IND Application to Initiate Phase 2b Clinical Trial with Enobosarm to Treat Muscle Loss Associated with Weight Loss Drugs

FDA IND clearance is an important development milestone in advancing enobosarm in combination with GLP-1 drugs for potentially higher quality weight loss than has been shown with GLP-1 drug alone ...

VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm -December 14, 2023 at 09:01 pm EST - Vimarsana News

VERU ALERT: Bragar Eagel & Squire, P.C. is Investigating Veru Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm -December 14, 2023 at 09:01 pm EST

Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Veru Inc. on behalf of long-term stockholders following a class action...